ClinicalTrials.gov
ClinicalTrials.gov Menu

Fasting Study of Olanzapine Tablets 20 mg and Zyprexa® Tablets 20 mg

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00647972
Recruitment Status : Terminated (during Period 1 due to numerous orthostatic AEs that occurred. Subsequently, RLD was reduced to 5 mg due to safety concerns.)
First Posted : April 1, 2008
Last Update Posted : November 23, 2009
Sponsor:
Information provided by:
Mylan Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : May 2003
  Study Completion Date : No date given